MICROBIX BIOSYSTEMS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.335 CAD | -1.47% |
|
+3.08% | -14.10% |
| 25/04 | Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology | MT |
| 25/04 | Microbix Collaborator Introduces New Lab Accreditation Program | CI |
Chart calendar Microbix Biosystems Inc.
50c8d0df192eda38b55daf319192.GytrLIgdmC4k0W8D0ow-E0H3F-JhFY2B693fFOLdxE0.WEMtReor6XdT4Bou4rVpfWzDeK0pf-C5nJGJIo-nliZrGzhF2nHtbEuaBA~6b4cbf6aed1bdd3e9f1adf820dd4c4a3
Upcoming events on Microbix Biosystems Inc.
Past events on Microbix Biosystems Inc.
| 16/04/2024 08:00 pm | Bloom Burton & Co. Healthcare Investor Conference |
| 27/03/2024 10:30 pm | Annual General Meeting |
| 13/03/2024 | EUROGIN International Multidisciplinary HPV Congress |
| 14/02/2024 08:30 pm | Q1 2024 Earnings Call |
| 14/02/2024 05:43 pm | Q1 2024 Earnings Release |
| 03/01/2024 09:30 pm | Q4 2023 Earnings Call |
| 21/12/2023 06:02 pm | Q4 2023 Earnings Release |
| 17/11/2023 08:30 pm | JW Marriott Turnberry Florida Capital Conference |
| 17/11/2023 08:30 pm | Business Update Call |
| 29/09/2023 | Muskoka Capital Conference |
| 06/09/2023 10:30 pm | Planet MicroCap Showcase |
| 14/08/2023 08:30 pm | Q3 2023 Earnings Call |
| 10/08/2023 05:27 pm | Q3 2023 Earnings Release |
| 23/07/2023 | American Association of Clinical Chemistry Conference |
| 15/06/2023 | American Society of Microbiology Conference |
| 16/05/2023 08:30 pm | Q2 2023 Earnings Call |
| 11/05/2023 05:00 pm | Q2 2023 Earnings Release |
| 26/04/2023 09:00 pm | Bloom Burton & Co Healthcare Investor Conference |
| 29/03/2023 10:30 pm | Annual General Meeting |
| 14/02/2023 09:30 pm | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 8,27 9,49 -12.77% | 14,5 15,3 -5.31% | 14,0 15,3 -8.42% | 12,4 12,7 -2.22% | 18,6 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -0,70 1,73 -140.53% | 4,41 4,50 -2.2% | 2,68 3,09 -13.47% | -1,18 -0,45 -165.53% | 3,03 |
|
EBIT | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 2,52 3,06 -17.71% | 1,37 2,16 -36.48% | 0,00 0,00 - | 0,00 |
|
Net income Million USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 2,52 3,06 -17.79% | 1,31 2,18 -39.88% | 0,00 0,00 - | 0,00 |
|
EPS CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,03 0,03 0% | 0,01 0,02 -35% | 0,00 -0,02 - | 0,02 |
| Announcement Date | 20/12/19 | 18/12/20 | 23/12/21 | 22/12/22 | 21/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,83 3,97 -3.53% | 3,75 4,68 -19.84% | 3,93 4,26 -7.88% | 3,18 4,02 -20.85% | 1,86 2,85 -34.68% | 3,13 3,07 1.92% | 4,13 3,56 16.08% | 3,21 3,57 -10.05% | 6,20 6,07 2.26% | 3,76 | 3,98 | 4,57 |
|
EBITDA Million USD | Released Forecast Spread | 1,06 1,18 -9.91% | 0,92 1,74 -47.14% | 0,84 0,68 23.34% | 0,03 0,62 -95.92% | -0,72 0,23 -413.79% | 0,32 -0,15 310.28% | -0,27 0,22 -221.82% | -0,51 0,22 -329.11% | 2,18 2,62 -16.9% | 0,07 | 0,22 | 0,52 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,70 0,85 -17.98% | 0,56 1,39 -59.55% | 0,50 0,44 14.98% | -0,97 0,56 -271.85% | 0,02 0,64 -96.31% | |||||||
|
Net income Million USD | Released Forecast Spread | 0,70 0,85 -18.12% | 0,56 1,40 -59.78% | 0,50 0,44 13.93% | -0,97 0,57 -270% | 0,02 0,64 -96.34% | |||||||
|
EPS CAD | Released Forecast Spread | 0,01 0,01 -40% | 0,01 0,01 -58.33% | 0,00 0,00 0% | 0,00 0,01 -160% | -0,01 -0,01 -28.57% | 0,00 0,00 - | -0,01 0,00 - | 0,01 0,00 1500% | ||||
| Announcement Date | 10/02/22 | 12/05/22 | 11/08/22 | 22/12/22 | 09/02/23 | 11/05/23 | 10/08/23 | 21/12/23 | 14/02/24 | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Microbix Biosystems Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MBX Stock
- Calendar Microbix Biosystems Inc.
